IRCT201602031556N85已完成3 期
Saffron in the treatment of postmenopausal hot flash : a double-blind,randomised and placebo-controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 years 至 65 years（—）
- 性别
- Female
入选标准
- •women aged between 45-65 years old; menopause.
- •Exclusion criteria: moderate to severe post-menopausal hot flushing-five episodes per day from 2 months ago; sopping of the mens from 12 month ago; receiving estrogen or progesterone during the last two months; receiving antidepressants during the last month; receving Selective Estrogen Receptor Modulators including raloxifen and tamoxifen during the last month; receiving aromatase inhibitors such as Anastrozole, Letrozole, Exemestane during the last month;receving Leuprolide acetate during the last month; receiving clonidine during the last month; receving gabapentine and pregabalin during the last month; receiving hot flushing reducing medications during the last month; receiving amino acid supplements during the last month.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Saffron and AlzheimerIRCT138711051556N1Tehran University of Medical Sciences50
招募中
3 期
Evaluation of the therapeutic effects of saffron on clinical and electrodiagnostic symptoms of patients with type 2 diabetesIRCT20100127003217N13Tabriz University of Medical Sciences60
已完成
不适用
Efficacy of saffron as an adjunct treatment for unremitted depression in adultsDepressionACTRN12618000748213Murdoch University160
招募中
3 期
Therapeutic effect of saffron extract in patients with chronic schizophreniaSchizophreniaIRCT20210525051404N1Kerman University of Medical Sciences40
已完成
不适用
Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerHot FlashesSleep DisordersBreast CancerNCT00084669Massachusetts General Hospital119